nejm 8/11/2022: alpha1 antitrypsin deficiency: fazirsiran therapy
Published 2 years ago • 969 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:24
middleton's allergy, 8th edition
-
8:41
ehj today - decades of the renin angiontensin system
-
2:01
phase ii trial of enasidenib in idh2-mutant mds
-
1:28
surpass et: ropeginterferon alfa-2b vs anagrelide for second-line essential thrombocythemia
-
0:52
afib untreated | jonathan sherman, m.d. | aurora denver cardiology associates
-
2:12
navtemadlin and its role in the treatment of r/r myelofibrosis
-
14:49
infection-induced and hybrid immunity | jefferson jones, md, mph, lcdr usphs
-
1:01
dr. naya antink, pediatrics
-
1:08
acute treatment of allergic reactions/anaphylaxis
-
15:08
development of pegylated liposomal amphotericin b for enhanced treatment of cutaneous leishmaniasis
-
2:47
nim vital™ nervassure™ and aps™ electrode
-
27:07
update: nash abstracts from aasld - mazen noureedin - 9:00 am
-
5:26
first-line osimertinib in egfr mutant ansclc patients: progression pattern and safety in the rea...
-
6:17
diagnosis and management of diverticular disease: nice guideline ng147
-
3:09
epi npam 2014 highlights
-
3:43
latest news & insight: january 8, 2015
-
2:02
international academy of cardiology: john a. eleftreriades, m.d.: thoracicaortic aneurysm
-
12:08
finals anaes saq49: anaemia